HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Postoperative mediastinitis due to methicillin resistant Staphylococcus epidermidis with low sensitivity to vancomycin].

AbstractBACKGROUND:
Vancomycin is the drug of choice for methicillin-resistant Staphylococcus. Antibiotherapy failure is rarely clinically related to Staphylococcus with vancomycin low susceptibility.
CASE REPORT:
A surgical cure of an aortic stenosis in a neonate was complicated by a Staphylococcus mediastinitis. After initiation of antibiotherapy with vancomycin and rifampin and surgical debridement, there was a rapid improvement. Few days later, failure of therapy was obvious. Despite continuous infusion of vancomycin, with a serum level of 29 mg/L, blood cultures were positive again to Staphylococcus. There was no endocarditis or inadequate surgical drainage. Susceptibility of the Staphylococcus was tested, looking for a tolerant strain. The vancomycin minimum bactericidal concentration was 30 mg/L (above usual value 2 to 8 mg/L), while the minimum inhibitory concentration was 3.75 mg/L. A higher dosage of vancomycin associated with fusidic acid was rapidly efficient, and total recovery was achieved.
CONCLUSION:
In case of failure of vancomycin therapy, despite correct serum levels, the susceptibility of the Staphylococcus strain has to be determined. A low susceptibility strain prescribes more prolonged combination of two antibiotics.
AuthorsS Hulin, Y Durandy
JournalArchives de pediatrie : organe officiel de la Societe francaise de pediatrie (Arch Pediatr) Vol. 4 Issue 12 Pg. 1204-6 (Dec 1997) ISSN: 0929-693X [Print] France
Vernacular TitleMédiastinite postopératoire à Staphylococcus epidermidis méthicilline-résistant, à sensibilité réduite à la vancomycine.
PMID9538424 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Fusidic Acid
  • Vancomycin
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Drug Therapy, Combination (therapeutic use)
  • Fusidic Acid (therapeutic use)
  • Humans
  • Infant, Newborn
  • Male
  • Mediastinitis (etiology, microbiology)
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Postoperative Complications (drug therapy)
  • Staphylococcal Infections (complications, drug therapy, microbiology)
  • Staphylococcus epidermidis
  • Surgical Wound Infection (drug therapy)
  • Vancomycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: